In this study, we demonstrated that DEL‐1 could alleviate myocardial fibrosis, inflammation, and cardiomyocyte apoptosis in MI in vitro and in vivo via regulating the Sirt1/NF‐κB signaling pathway. Here, NFKB1 is linked to myocardial infarction.